Literature DB >> 14683521

Estrogen receptor modulators: relationships of ligand structure, receptor affinity and functional activity.

Owen B Wallace1, Timothy I Richardson, Jeffrey A Dodge.   

Abstract

The estrogen receptor is a regulator of a wide range of physiological functions, including the female reproductive system, in addition to bone, cardiovascular and CNS function. ER ligands have been approved for the treatment of menopausal symptoms, breast cancer and osteoporosis, however the search continues for new modulators of ER function with improved properties. Progress in medicinal chemistry programs has resulted in the identification of structurally diverse molecules with unique biological properties. Recent advances in the design and synthesis of these non-steroidal and steroidal estrogen receptor ligands is reviewed. The relationship between the structural features of the ligand and receptor function is also discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14683521     DOI: 10.2174/1568026033451727

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  3 in total

Review 1.  The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response.

Authors:  Francisco J Quintana
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

2.  Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer.

Authors:  Christopher G Mayne; Weiyi Toy; Kathryn E Carlson; Trusha Bhatt; Sean W Fanning; Geoffrey L Greene; Benita S Katzenellenbogen; Sarat Chandarlapaty; John A Katzenellenbogen; Emad Tajkhorshid
Journal:  Mol Cancer Res       Date:  2021-05-21       Impact factor: 5.852

3.  Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor alpha.

Authors:  Jun Yan; Yong-Sik Kim; Xiao-Ping Yang; Michael Albers; Manfred Koegl; Anton M Jetten
Journal:  Nucleic Acids Res       Date:  2007-02-20       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.